Cited by 1,743Cytokine Signaling Pathways and InteractionsProtein Tyrosine PhosphatasesNF-κB Signaling Pathways

The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.

STATs in oncogenesis

Bowman, Tammy, Garcia, Roy, Turkson, James, Jove, Richard·2000·Oncogene

DOI 10.1038/sj.onc.1203527

Open this paper in CoChat — free account

Abstract

Since their discovery as key mediators of cytokine signaling, considerable progress has been made in defining the structure-function relationships of Signal Transducers and Activators of Transcription (STATs). In addition to their central roles in normal cell signaling, recent studies have demonstrated that diverse oncoproteins can activate specific STATs (particularly Stat3 and Stat5) and that constitutively-activated STAT signaling directly contributes to oncogenesis. Furthermore, extensive surveys of primary tumors and cell lines derived from tumors indicate that inappropriate activation of specific STATs occurs with surprisingly high frequency in a wide variety of human cancers. Together, these findings provide compelling evidence that aberrant STAT activation associated with oncogenesis is not merely adventitious but instead contributes to the process of malignant transformation. These studies are beginning to reveal the molecular mechanisms leading to STAT activation in the context of oncogenesis, and candidate genes regulated by STATs that may contribute to oncogenesis are being identified. Recent studies suggest that activated STAT signaling participates in oncogenesis by stimulating cell proliferation and preventing apoptosis. This review presents the evidence for critical roles of STATs in oncogenesis and discusses the potential for development of novel cancer therapies based on mechanistic understanding of STAT signaling. Oncogene (2000).

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1203527

Cites

152 of 152 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
STATs and Gene Regulation
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells
Druker, B. J., Tamura, S., Buchdunger, E., Ohno-Jones, S., Segal, G. M., Fanning, S., Zimmermann, J., & Lydon, N. (1996) · Nature Medicine · doi:10.1038/nm0596-561 · Cited by 3,652
Stat3 as an Oncogene
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
Maximal activation of transcription by statl and stat3 requires both tyrosine and serine phosphorylation
Wen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
TRANSCRIPTIONAL RESPONSES TO POLYPEPTIDE LIGANDS: The JAK-STAT Pathway
Schindler, C., & Darnell, J. E. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003201 · Cited by 1,808
Targeted Disruption of the Stat1 Gene in Mice Reveals Unexpected Physiologic Specificity in the JAK–STAT Signaling Pathway
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656

Flagged first, then by citations

Show all 152 references

Research works printed but not linked: 7

Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse JF, Capiod JC, Delobel J, Weber-Nordt R, Dusanter-Fourt I, Dreyfus F, Groner B and Prin L . 1996 Blood 87: 1692–1697 · DOI
Hallek M, Leif Bergsagel P and Anderson KC . 1998 Blood 91: 3–21 · DOI
Ho JM, Beattie BK, Squire JA, Frank DA and Barber DL . 1999 Blood 93: 4354–4364 · DOI
Liu RY, Fan C, Garcia R, Jove R and Zuckerman KS . 1999 Blood 93: 2369–2379 · DOI
Skorski T, Nieborowska-Skorska M, Wlodarski P, Wasik M, Trotta R, Kanakaraj P, Salomoni P, Antonyak M, Martinez R, Majewski M, Wong A, Perussia B and Calabretta B . 1998 Blood 91: 406–418 · DOI
Sun WH, Pabon C, Alsayed Y, Huang PP, Jandeska S, Uddin S, Platanias LC and Rosen ST . 1998 Blood 91: 570–576 · DOI
Wang YH, Wharton W, Garcia R, Kraker A, Jove R and Pledger WJ . 2000 Oncogene in press

Sorted by citations

Items 101–200 of 999

Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling
Sinibaldi, D., Wharton, W., Turkson, J., Bowman, T. L., Pledger, W. J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203947 · Cited by 290
Self-citation
Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma
Skinnider, B., Elia, A., Gascoyne, R. D., Patterson, B. J., Trümper, L. H. P., Kapp, U., & Mak, T. W. (2002) · Blood · doi:10.1182/blood.v99.2.618 · Cited by 298
Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein
Kotha, A., Sekharam, M., Cilenti, L., Siddiquee, K., Khaled, A. R., Zervos, A. S., Carter, B., Turkson, J., & Jove, R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0268 · Cited by 289
Self-citation
Cyclin D1 Is Transcriptionally Regulated by and Required for Transformation by Activated Signal Transducer and Activator of Transcription 3
Leslie, K., Lang, C., Devgan, G., Azare, J., Berishaj, M., Gerald, W., Kim, Y. B., Paz, K., Darnell, J. E., Albanese, C., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2203 · Cited by 285
STAT Protein Interference and Suppression of Cytokine Signal Transduction by Measles Virus V Protein
Palosaari, H., Parisien, J.-P., Rodriguez, J. J., Ulane, C. M., & Horvath, C. M. (2003) · Journal of Virology · doi:10.1128/jvi.77.13.7635-7644.2003 · Cited by 292
Targeting STAT3 affects melanoma on multiple fronts
Kortylewski, M., Jove, R., & Yu, H. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-1580-1 · Cited by 286
Self-citation
Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma
Subramaniam, A., Shanmugam, M. K., Perumal, E., Li, F., Nachiyappan, A., Dai, X., Swamy, S. N., Ahn, K. S., Kumar, A. P., Tan, B. K. H., et al. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.10.002 · Cited by 284
High local protein concentrations at promoters: Strategies in prokaryotic and eukaryotic cells
Dröge, P., & Müller‐Hill, B. (2001) · BioEssays · doi:10.1002/1521-1878(200102)23:2 · Cited by 60
Targeting Stat3 in cancer therapy
Jing, N., & Tweardy, D. J. (2005) · Anti-Cancer Drugs · doi:10.1097/00001813-200507000-00002 · Cited by 281
Stat3 regulates microtubules by antagonizing the depolymerization activity of stathmin
Ng, D. C. H., Li-n, B., Lim, C. P., Huang, G., Zhang, T., Poli, V., & Cao, X. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200503021 · Cited by 281
Coordinately up-regulated genes in ovarian cancer.
Hough, C. D., Cho, K. R., Zonderman, A. B., Schwartz, D. R., & Morin, P. J. (2001) · PubMed · Cited by 277
Cellular and molecular signal transduction pathways modulated by rituximab (rituxan, anti-CD20 mAb) in non-Hodgkin's lymphoma: implications in chemosensitization and therapeutic intervention
Jazirehi, A. R., & Bonavida, B. (2005) · Oncogene · doi:10.1038/sj.onc.1208349 · Cited by 277
Untitled work
(2003) · PubMed · Cited by 272
Efficient Generation of Astrocytes from Human Pluripotent Stem Cells in Defined Conditions
Shaltouki, A., Peng, J., Liu, Q., Rao, M. S., & Zeng, X. (2013) · Stem Cells · doi:10.1002/stem.1334 · Cited by 273
Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells
Burke, W. M., Jin, X., Lin, H.-J. L., Huang, M., Liu, R., Reynolds, R. K., & Lin, J. (2001) · Oncogene · doi:10.1038/sj.onc.1204990 · Cited by 271
BRCA1 gene in breast cancer
Rosen, E. M., Fan, S., Pestell, R. G., & Goldberg, I. D. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10257 · Cited by 279
LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival
Butzkueven, H., Zhang, J., Soilu‐Hänninen, M., Hochrein, H., Chionh, F. J. M., Shipham, K. A., Emery, B., Turnley, A. M., Petratos, S., Ernst, M., et al. (2002) · Nature Medicine · doi:10.1038/nm0602-613 · Cited by 263
Therapeutic Potential of Certain Terpenoids as Anticancer Agents: A Scoping Review
Kamran, S., Sinniah, A., Abdulghani, M. A. M., & Alshawsh, M. A. (2022) · Cancers · doi:10.3390/cancers14051100 · Cited by 277
The complexity of targeting EGFR signalling in cancer: From expression to turnover
Sebastian, S., Settleman, J. E., Reshkin, S. J., Azzariti, A., Bellizzi, A., & Paradiso, A. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.06.001 · Cited by 266
Antiviral potential of curcumin
Mathew, D. C., & Hsu, W. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.12.017 · Cited by 263
Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity
Turkson, J., Kim, J. S., Zhang, S., Yuan, J., Huang, M., Glenn, M. P., Haura, E. B., Sebti, S. M., Hamilton, A. D., & Jove, R. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.261.3.3 · Cited by 258
Self-citation
Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer
Scholz, A., Heinze, S., Detjen, K. M., Peters, M., Welzel, M., Hauff, P., Schirner, M., Wiedenmann, B., & Rosewicz, S. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01064-3 · Cited by 255
Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
Montero, P., Milara, J., Roger, I., & Cortijo, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126211 · Cited by 263
Cucurbitacins - An insight into medicinal leads from nature
Aeri, V., Kaushik, U., & Mir, S. R. (2015) · Pharmacognosy Reviews/Bioinformatics Trends/Pharmacognosy review · doi:10.4103/0973-7847.156314 · Cited by 253
Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1
Shen, Y., Devgan, G., Darnell, J. E., & Bromberg, J. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1543 · Cited by 249
Cooperation between STAT3 and c-Jun Suppresses Fas Transcription
Ivanov, V. N., Bhoumik, A., Ma, K., Raz, R., Owen‐Schaub, L. B., Levy, D. E., Horvath, C. M., & Ronai, Z. A. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00199-x · Cited by 244
Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-β1 production
Ogata, H., Chinen, T., Yoshida, T., Kinjyo, I., Takaesu, G., Shiraishi, H., Iida, M., Kobayashi, T., & Yoshimura, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209281 · Cited by 246
Signal Transducer and Activator of Transcription 3 Is Required for the Oncogenic Effects of Non–Small-Cell Lung Cancer–Associated Mutations of the Epidermal Growth Factor Receptor
Alvarez, J. V., Greulich, H. E., Sellers, W. R., Meyerson, M. M., & Frank, D. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3757 · Cited by 243
Activation of Stat3 in Primary Tumors from High-Risk Breast Cancer Patients Is Associated with Elevated Levels of Activated Src and Survivin Expression
Diaz, N., Minton, S. E., Cox, C., Bowman, T. L., Gritsko, T., Garcia, R., Eweis, I., Wloch, M., Livingston, S., Seijo, E., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1749 · Cited by 245
Self-citation
Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action
Wong, Y. K., Xu, C., Kalesh, K., He, Y., Lin, Q., Wong, W. S. F., Shen, H., & Wang, J. (2017) · Medicinal Research Reviews · doi:10.1002/med.21446 · Cited by 244
Landscape of EGFR signaling network in human cancers: Biology and therapeutic response in relation to receptor subcellular locations
Han, W., & Lo, H. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.01.011 · Cited by 245
Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.
Alas, S., & Bonavida, B. (2003) · PubMed · Cited by 239
Personalized Medicine in Non–Small-Cell Lung Cancer: Is KRAS a Useful Marker in Selecting Patients for Epidermal Growth Factor Receptor–Targeted Therapy?
Roberts, P. J., Stinchcombe, T. E., Der, C. J., & Socinski, M. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4365 · Cited by 245
Stat3: linking inflammation to epithelial cancer - more than a "gut" feeling?
Jarnicki, A., Putoczki, T. L., & Ernst, M. (2010) · Cell Division · doi:10.1186/1747-1028-5-14 · Cited by 246
Hepatitis C virus, ER stress, and oxidative stress
Tardif, K. D., Waris, G., & Siddiqui, A. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2005.02.004 · Cited by 239
EGFR signaling pathway in breast cancers: from traditional signal transduction to direct nuclear translocalization
Lo, H., Hsu, S.-C., & Hung, M. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9011-0 · Cited by 240
Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation
Yoshida, T., Hanada, T., Tokuhisa, T., Kosai, K.-I., Sata, M., Kohara, M., & Yoshimura, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012127 · Cited by 236
Ups and downs: The STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling
Regis, G., Pensa, S., Boselli, D., Novelli, F., & Poli, V. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.06.004 · Cited by 241
Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms
Haga, S., Terui, K., Zhang, H. Q., Enosawa, S., Ogawa, W., Inoue, H., Okuyama, T., Takeda, K., Akira, S., Ogino, T., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17970 · Cited by 237
Keratinocyte Apoptosis in Epidermal Development and Disease
Raj, D., Brash, D. E., & Grossman, D. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700008 · Cited by 246
Ursolic Acid Inhibits STAT3 Activation Pathway Leading to Suppression of Proliferation and Chemosensitization of Human Multiple Myeloma Cells
Pathak, A., Bhutani, M., Nair, S. A., Ahn, K. S., Chakraborty, A., Kadara, H. N., Guha, S., Sethi, G., & Aggarwal, B. B. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0348 · Cited by 238
Signal Transducer and Activator of Transcription-3: A Molecular Hub for Signaling Pathways in Gliomas
Brantley, E. C., & Benveniste, E. N. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-2180 · Cited by 239
Epigallocatechin‐3‐gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR‐related pathways of signal transduction
Masuda, M., Suzui, M., Lim, J. T. E., Deguchi, A., Soh, J., & Weinstein, I. B. (2002) · Journal of Experimental Therapeutics and Oncology · doi:10.1046/j.1359-4117.2002.01062.x · Cited by 235
Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway
Ren, X., Duan, L., He, Q., Zhang, Z., Zhou, Y., Wu, D., Pan, J., Pei, D., & Ding, K. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100146z · Cited by 232
Dasatinib Inhibits Migration and Invasion in Diverse Human Sarcoma Cell Lines and Induces Apoptosis in Bone Sarcoma Cells Dependent on Src Kinase for Survival
Shor, A. C., Keschman, E. A., Lee, F. Y., Muro‐Cacho, C., Letson, G. D., Trent, J. C., Pledger, W. J., & Jove, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3469 · Cited by 234
Self-citation
JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia
Satriotomo, I., Bowen, K. K., & Vemuganti, R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04051.x · Cited by 227
Interleukin 6 Supports the Maintenance of p53 Tumor Suppressor Gene Promoter Methylation
Hodge, D. R., Peng, B. H., Cherry, J. C., Hurt, E. M., Fox, S. D., Kelley, J. A., Munroe, D. J., & Farrar, W. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3589 · Cited by 226
STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells
Pawlus, M. R., Wang, L., & Hu, C. (2013) · Oncogene · doi:10.1038/onc.2013.115 · Cited by 236
STAT3 as a therapeutic target in head and neck cancer
Leeman‐Neill, R. J., Lui, V. W. Y., & Grandis, J. R. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.3.231 · Cited by 225
Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin‐6/STAT3 signaling pathway
Zhang, J., Li, Z., Liu, L., Wang, Q., Li, S., Chen, D., Hu, Z., Yu, T., Ding, J., Li, J., et al. (2017) · Hepatology · doi:10.1002/hep.29405 · Cited by 221
GRIM‐19, a death‐regulatory gene product, suppresses Stat3 activity via functional interaction
Lufei, C., Ma, J., Huang, G., Zhang, T., Novotny‐Diermayr, V., Ong, C. T., & Cao, X. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg135 · Cited by 220
Series Introduction: JAK-STAT signaling in human disease
Schindler, C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15644 · Cited by 220
Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells
Konnikova, L., Kotecki, M., Kruger, M. M., & Cochran, B. (2003) · BMC Cancer · doi:10.1186/1471-2407-3-23 · Cited by 219
Targeting the JAK/STAT Signaling Pathway Using Phytocompounds for Cancer Prevention and Therapy
Bose, S., Banerjee, S., Mondal, A., Chakraborty, U., Pumarol, J., Croley, C. R., & Bishayee, A. (2020) · Cells · doi:10.3390/cells9061451 · Cited by 219
Role of Jak Kinases and STATs in Cytokine Signal Transduction
Leonard, W. J. (2001) · International Journal of Hematology · doi:10.1007/bf02981951 · Cited by 220
Identification of STAT3 as a substrate of receptor protein tyrosine phosphatase T
Zhang, X., Guo, A., Yu, J., Possemato, A. P., Chen, Y., Zheng, W., Polakiewicz, R. D., Kinzler, K. W., Vogelstein, B., Velculescu, V. E., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611665104 · Cited by 214
Flavonoids as Protein Kinase Inhibitors for Cancer Chemoprevention: Direct Binding and Molecular Modeling
Hou, D., & Kumamoto, T. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2816 · Cited by 216
STAT-3 Activation Is Required for Normal G-CSF-Dependent Proliferation and Granulocytic Differentiation
McLemore, M. L., Grewal, S. S., Liu, F., Archambault, A. S., Poursine‐Laurent, J., Haug, J., & Link, D. C. (2001) · Immunity · doi:10.1016/s1074-7613(01)00101-7 · Cited by 209
Signaling by Type I and II cytokine receptors: ten years after
Gadina, M., Hilton, D. J., Johnston, J. A., Morinobu, A., Lighvani, A., Zhou, Y., Visconti, R., & O’Shea, J. J. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00228-4 · Cited by 209
Epidermal growth factor family of receptors in preneoplasia and lung cancer: perspectives for targeted therapies
Hirsch, F. R., Scagliotti, G. V., Langer, C. J., Varella‐Garcia, M., & Franklin, W. A. (2003) · Lung Cancer · doi:10.1016/s0169-5002(03)00137-5 · Cited by 208
Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration
Michaud‐Levesque, J., Bousquet-Gagnon, N., & Béliveau, R. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.02.017 · Cited by 209
Small Molecule Inhibitors of Signal Transducer and Activator of Transcription 3 (Stat3) Protein
Debnath, B., Xu, S., & Neamati, N. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300207s · Cited by 206
Trophoblast invasion: the role of intracellular cytokine signalling via signal transducer and activator of transcription 3 (STAT3)
Fitzgerald, J. S., Poehlmann, T. G., Schleußner, E., & Markert, U. R. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn010 · Cited by 208
Cancer cell signaling pathways targeted by spice-derived nutraceuticals
Sung, B., Prasad, S., Yadav, V. R., & Aggarwal, B. B. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.630551 · Cited by 204
STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers
Wang, X., Crowe, P. J., Goldstein, D., & Yang, J. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1568 · Cited by 204
Leptin-induced Growth Stimulation of Breast Cancer Cells Involves Recruitment of Histone Acetyltransferases and Mediator Complex to CYCLIN D1 Promoter via Activation of Stat3
Saxena, N. K., Vertino, P. M., Anania, F. A., & Sharma, D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609798200 · Cited by 203
Activation of IL-6R/JAK1/STAT3 Signaling Induces De Novo Resistance to Irreversible EGFR Inhibitors in Non–Small Cell Lung Cancer with T790M Resistance Mutation
Kim, S. M., Kwon, O.-J., Hong, Y. K., Kim, J. H., Solca, F., Ha, S., Soo, R. A., Christensen, J. G., Lee, J. H., & Cho, B. C. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0311 · Cited by 203
Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells
Li, F., Fernandez, P. P., Rajendran, P., Hui, K. M., & Sethi, G. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.12.003 · Cited by 207
Epstein-Barr Virus Infection Alters Cellular Signal Cascades in Human Nasopharyngeal Epithelial Cells
Lo, A. K. F., Lo, K. W., Tsao, S. W., Wong, H., Hui, J. W., To, K. F., Hayward, S. D., Chui, Y., Lau, Y., Takada, K., et al. (2006) · Neoplasia · doi:10.1593/neo.05625 · Cited by 201
EGFR-TKI resistance in NSCLC patients: mechanisms and strategies.
Lin, Y., Wang, X., & Jin, H. (2014) · Europe PMC (PubMed Central) · Cited by 198
Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis
Zhang, Y.-W., Wang, L., Jove, R., & Woude, G. F. V. (2002) · Oncogene · doi:10.1038/sj.onc.1205004 · Cited by 203
Self-citation
Capsaicin Is a Novel Blocker of Constitutive and Interleukin-6–Inducible STAT3 Activation
Bhutani, M., Pathak, A., Nair, S. A., Kunnumakkara, A. B., Guha, S., Sethi, G., & Aggarwal, B. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2575 · Cited by 197
Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives
Spano, J., Fagard, R., Soria, J., Rixe, O., Khayat, D., & Milano, G. A. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi057 · Cited by 200
Autophagy and epithelial–mesenchymal transition: an intricate interplay in cancer
Gugnoni, M., Sancisi, V., Manzotti, G., Gandolfi, G., & Ciarrocchi, A. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.415 · Cited by 205
A Novel Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Activities and Exhibits Potent Growth-Suppressive Activity in Human Cancer Cells
Lin, L., Hutzen, B. J., Li, P., Ball, S. L., Zuo, M., Deangelis, S., Foust, E., Sobo, M., Friedman, L., Bhasin, D., et al. (2010) · Neoplasia · doi:10.1593/neo.91196 · Cited by 196
Regulation of let-7 and its target oncogenes (Review)
WANG, X., Cao, L., Wang, Y., Wang, X., Liu, N., & You, Y. (2012) · Oncology Letters · doi:10.3892/ol.2012.609 · Cited by 191
The STAT3 pathway as a therapeutic target in head and neck cancer: barriers and innovations
Geiger, J. L., Grandis, J. R., & Bauman, J. E. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2015.11.022 · Cited by 193
The Role of STAT3 in Non-Small Cell Lung Cancer
Harada, D., Takigawa, N., & Kiura, K. (2014) · Cancers · doi:10.3390/cancers6020708 · Cited by 195
Requirement of Histone Deacetylase Activity for Signaling by STAT1
Klampfer, L., Huang, J., Swaby, L.-A., & Augenlicht, L. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401359200 · Cited by 191
Differential Regulation of STAT Family Members by Glycogen Synthase Kinase-3
Beurel, E., & Jope, R. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802481200 · Cited by 194
STAT3 and apoptosis challenges in cancer
Fathi, N., Rashidi, G., Khodadadi, A., Shahi, S., & Sharifi, S. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.05.121 · Cited by 191
An Oxazole-Based Small-Molecule Stat3 Inhibitor Modulates Stat3 Stability and Processing and Induces Antitumor Cell Effects
Siddiquee, K., Gunning, P. T., Glenn, M. P., Katt, W. P., Zhang, S., Schrock, C. E., Sebti, S. M., Jove, R., Hamilton, A. D., & Turkson, J. (2007) · ACS Chemical Biology · doi:10.1021/cb7001973 · Cited by 188
Self-citation
Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity
Turkson, J., Zhang, S., Palmer, J., Kay, H., Stanko, J., Mora, L. B., Sebti, S., Yu, H., & Jove, R. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1533.3.12 · Cited by 188
Self-citation
SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition
Weber, A., Hengge, U. R., Bardenheuer, W., Tischoff, I., Sommerer, F., Markwarth, A., Dietz, A., Wittekind, C., & Tannapfel, A. (2005) · Oncogene · doi:10.1038/sj.onc.1208818 · Cited by 190
Hydrodynamic gene delivery of interleukin-22 protects the mouse liver from concanavalin A-, carbon tetrachloride-, and Fas ligand-induced injury via activation of STAT3.
Pan, H., Hong, F., Radaeva, S., & Gao, B. (2004) · PubMed · Cited by 186
IL-17 Enhances Tumor Development in Carcinogen-Induced Skin Cancer
Wang, L., Yi, T., Zhang, W., Pardoll, D. M., & Yu, H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0775 · Cited by 191
Signalling pathways regulating the invasive differentiation of human trophoblasts: a review
Pollheimer, J., & Knöfler, M. (2005) · Placenta · doi:10.1016/j.placenta.2004.11.013 · Cited by 186
The IKK-related kinases: from innate immunity to oncogenesis
Clément, J.-F., Meloche, S., & Servant, M. J. (2008) · Cell Research · doi:10.1038/cr.2008.273 · Cited by 189
STAT3-Mediated Autophagy Dependence Identifies Subtypes of Breast Cancer Where Autophagy Inhibition Can Be Efficacious
Maycotte, P., Gearheart, C. M., Barnard, R., Aryal, S., Levy, J. M. M., Fosmire, S. P., Hansen, R. J., Morgan, M. J., Porter, C. C., Gustafson, D. L., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3470 · Cited by 188
Loss of Androgen Receptor Expression Promotes a Stem-like Cell Phenotype in Prostate Cancer through STAT3 Signaling
Schroeder, A., Herrmann, A., Cherryholmes, G. A., Kowolik, C. M., Buettner, R., Pal, S. K., Yu, H., Müller‐Newen, G., & Jove, R. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0594 · Cited by 192
Self-citation
MicroRNA miR-21 Regulates the Metastatic Behavior of B16 Melanoma Cells
Yang, C. H., Yue, J., Pfeffer, S. R., Handorf, C. R., & Pfeffer, L. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.285098 · Cited by 186
Resveratrol inhibits STAT3 signaling pathway through the induction of SOCS-1: Role in apoptosis induction and radiosensitization in head and neck tumor cells
Baek, S. H., Ko, J., Lee, H., Jung, J., Kong, M., Lee, J.-W., Lee, J., Chinnathambi, A., Zayed, M., Alharbi, S. A., et al. (2016) · Phytomedicine · doi:10.1016/j.phymed.2016.02.011 · Cited by 184
miR-135b mediates NPM-ALK–driven oncogenicity and renders IL-17–producing immunophenotype to anaplastic large cell lymphoma
Matsuyama, H., Suzuki, H. I., Nishimori, H., Noguchi, M., Yao, T., Komatsu, N., Mano, H., Sugimoto, K., & Miyazono, K. (2011) · Blood · doi:10.1182/blood-2011-05-354654 · Cited by 182
Impact of Stat3 activation upon skin biology: A dichotomy of its role between homeostasis and diseases
Sano, S., Chan, K. S., & DiGiovanni, J. (2007) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2007.05.016 · Cited by 182
Disruption of STAT3 by Niclosamide Reverses Radioresistance of Human Lung Cancer
You, S., Li, R., Park, D., Xie, M., Sica, G., Cao, Y., Xiao, Z., & Deng, X. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0608 · Cited by 184
Functional analysis of transcription factor binding sites in human promoters
Whitfield, T. W., Wang, J., Collins, P. J., Partridge, E. C., Aldred, S. F., Trinklein, N. D., Myers, R., & Weng, Z. (2012) · Genome biology · doi:10.1186/gb-2012-13-9-r50 · Cited by 187
Evaluation of potential Stat3-regulated genes in human breast cancer
Hsieh, F.-C., Cheng, G., & Lin, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.075 · Cited by 180
Src Kinases Mediate STAT Growth Pathways in Squamous Cell Carcinoma of the Head and Neck
Xi, S., Zhang, Q. H., Dyer, K. F., Lerner, E. C., Smithgall, T. E., Gooding, W. E., Kamens, J., & Grandis, J. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303499200 · Cited by 181
A novel small-molecule disrupts Stat3 SH2 domain–phosphotyrosine interactions and Stat3-dependent tumor processes
Zhang, X., Yue, P., Fletcher, S., Zhao, W., Gunning, P. T., & Turkson, J. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.001 · Cited by 179
Self-citation
The Coactivator of Transcription CREB-binding Protein Interacts Preferentially with the Glycosylated Form of Stat5
Gewinner, C. A., Hart, G. W., Zachara, N. E., Cole, R. N., Beisenherz-Huss, C., & Groner, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306449200 · Cited by 187

Authors: Bowman, T., Garcia, R., Turkson, J., & Jove, R.
Affiliations: Moffitt Cancer Center (US)
University of South Florida (US)
ORCID: Turkson, James
Venue: Oncogene
Publisher: Springer Science and Business Media LLC
Published: 2000-05-25
Volume: 19
Issue: 21
Pages: 2474-2488
ISSN: 0950-9232 (ISSN-L)
1476-5594
DOI: 10.1038/sj.onc.1203527
OpenAlex: W2024282024
Cited by: 1,743
References: 152
Citations by year: 2026: 16 · 2025: 18 · 2024: 18 · 2023: 22 · 2022: 39 · 2021: 48 · 2020: 44 · 2019: 45 · 2018: 59 · 2017: 63 · 2016: 58 · 2015: 104 · 2014: 80 · 2013: 82 · 2012: 89
FWCI: 7.25
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Oncogene (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
Keywords: STAT, signal transducer and activator of transcription, carcinogenesis, STAT3, STAT5, malignant transformation, cytokine signaling, cell proliferation, apoptosis, cancer therapy targets, cancer cell lines
MeSH terms: Animals, Cell Transformation, Neoplastic, DNA-Binding Proteins, Humans, Neoplasms, Phosphorylation, Phosphoserine, Protein-Tyrosine Kinases, Signal Transduction, Oncogene Proteins, Trans-Activators, Gene Expression Regulation, Neoplastic, STAT1 Transcription Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

STATs in oncogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks